Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
NEW YORK, April 26, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0845627/Contract-Manufacturing-Organizations-to-2018---Cost-Advantages-and-Improving-Quality-Standards-Build-Confidence-and-Encourage-Foreign-Investment-in-Asian-CMOs.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Manufacturing
Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
Summary
GBI Research, the leading business intelligence provider, has released its latest report, "Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs", which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry. The report provides a comprehensive insight into the size of the CMO market, and includes forecasts, key reasons for outsourcing, the geographical landscape of CMO's, profiles of top CMOs, regulatory frameworks, drivers and restraints and deals analysis.
This report is built using data and information sourced from proprietary databases, primary and secondary research, and uses in-house analysis from GBI Research's team of industry experts.
GBI Research suggests that the global CMO market is set to grow steadily due to increased outsourcing of pharmaceutical production for Western pharmaceutical manufacturers to Asian countries. The global CMO market was valued at $26 billion in 2010. This market grew at a Compound Annual Growth Rate (CAGR) of 10.7% over 2008 when the market was approximately $21.2 billion. The major factor driving this market is the increase in the sourcing of biologics and generic manufacturing. The market is forecast to reach approximate revenues of $59.9 billion by 2018. The market is forecast to grow at a CAGR of 11% between 2010 and 2018.
Scope
- Detailed overview of the CMO industry.
- Annualized market data and forecasts for the CMO market.
- Detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
- Detailed discussion of the regulatory framework.
- Company profiles of major CMOs, including the key services offered by then, their financial information, and details on their worldwide presence.
- Analysis of partnership deals and Merger and Acquisition (M&A) deals involving key companies.
Reasons to buy
- Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities.
- Understand the factors shaping the CMO market.
- Identify the top players in the CMO market, financial revenues, geographical presence and key services offered.
- Analyze the key geographies that are lucrative markets for the outsourcing of CMO.
- Analyze the trends in licensing and M&A deals and explore potential investment opportunities
- Understand upcoming trends that are poised to drive the future growth of the CMO industry.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Contract Manufacturing Organizations to 2018 - Introduction 7
2.1 GBI Research Guide 7
3 Contract Manufacturing Organizations to 2018 - Industry Overview 8
3.1 Current Status of Pharmaceutical Industry 8
3.2 Cost Optimization Steps for the Pharmaceutical Companies 8
3.2.1 Reduction in Physical Assets 9
3.2.2 Downsizing Manufacturing 9
3.2.3 Reduction in R&D Spending 10
3.3 What CMOs are and Reasons for Outsourcing to Them 12
3.3.1 Different Types of CMOs and the Range of Services Provided by Them 12
3.3.2 How Does Outsourcing to CMOs Take Place? 14
3.3.3 Key Outsourcing Models 16
3.3.4 Key Benefits of Outsourcing 18
4 Contract Manufacturing Organizations to 2018 - Market Characterization 21
4.1 Market Forecasts 21
5 Contract Manufacturing Organizations to 2018 - Geographical Landscape 23
5.1 Introduction 23
5.2 Established Markets 24
5.2.1 The US CMO Market 24
5.2.2 The Eastern European CMO Market 25
5.3 Emerging Markets 27
5.3.1 The Indian CMO Market 27
5.3.2 The Chinese CMO Market 29
6 Contract Manufacturing Organizations to 2018 - Market Drivers and Restraints 32
6.1 Global CMO Market Drivers 33
6.1.1 Availability of Low-cost Skilled Manpower 33
6.1.2 Increasing Government Sanctions are Favoring CMOs 34
6.1.3 Increased Consumption of Generics 35
6.1.4 Better Intellectual Property Rights Protection 40
6.1.5 Increasing Uptake of Biologics and Entry of Biosimilars into Market 41
6.2 Global CMO Market Restraints 42
6.2.1 Capacity Utilization Issues Affecting the Profitability of CMOs 42
6.2.2 Reduced Number of New Drug Approvals 42
6.2.3 Complex Cost Structures in Outsourcing 45
7 Contract Manufacturing Organizations to 2018 - Regulatory Framework 46
7.1 Overview 46
7.2 FDA Guidelines 46
7.2.1 Organization and Personnel 46
7.2.2 Building and Facilities 47
7.2.3 Process Equipment 47
7.2.4 Control of Raw Materials 47
7.2.5 Production and Process Controls 47
7.2.6 Packaging and Labeling 47
7.2.7 Holding and Distribution 48
7.2.8 Key Changes in FDA Guidelines 48
7.3 EMA Guidelines 49
7.3.1 Quality Management 50
7.3.2 Production Activities 51
7.3.3 Buildings and Facilities 51
7.3.4 Process Equipment 52
7.3.5 Materials Management 52
7.3.6 Packaging and Labeling 52
7.3.7 Key Changes in EMA Guidelines 53
7.4 PIC/S 53
8 Contract Manufacturing Organizations to 2018 - Key Aspects of the Upstream and Downstream Processing CMO Industry 55
8.1 Comparison of Upstream Processing and Downstream Processing 55
8.1.1 CMO Market Size for Upstream Processing 56
8.1.2 CMO Market Size for Downstream Processing 57
9 Contract Manufacturing Organizations to 2018 - Key CMO Participants 58
9.1 Catalent Pharma Solutions, Inc. 58
9.2 Lonza Group AG 60
9.3 Royal DSM N.V. 62
9.4 Piramal Healthcare Ltd. 64
9.5 Jubilant Life Sciences 65
9.6 Evonik Industries AG 67
9.7 Patheon Inc. 68
9.8 Fareva Holding 69
9.9 Cambrex 70
9.10 Boehringer Ingelheim 71
10 Contract Manufacturing Organizations to 2018 - Strategic Consolidations within the Global CMO Market 72
10.1 Mergers and Acquisitions 72
10.1.1 Summary of Mergers and Acquisitions 72
10.2 Co-development Deals 73
10.2.1 Summary of Co-development Deals 74
10.3 Licensing Deals 76
10.3.1 Summary of Licensing Deals 77
11 Contract Manufacturing Organizations to 2018 - Appendix 80
11.1 Market Definitions 80
11.2 Abbreviations 80
11.3 Research Methodology 81
11.3.1 Coverage 82
11.3.2 Secondary Research 82
11.3.3 Primary Research 82
11.3.4 Expert Panel Validation 83
11.4 Contact Us 83
11.5 Disclaimer 83
11.6 Sources 83
1.1 List of Tables
Table 1: CMO Market, Global, Revenue ($bn), 2008-2010 21
Table 2: CMO Market, Global, Revenue Forecasts ($bn), 2010-2018 21
Table 3: CMO Market, The US, Revenue ($bn), 2008-2010 24
Table 4: CMO Market, The US, Revenue Forecasts ($bn), 2010-2018 25
Table 5: CMO Market, The Central and Eastern Europe, Revenue ($bn), 2008-2010 26
Table 6: CMO Market, The Central and Eastern Europe, Revenue Forecasts ($bn), 2010-2018 26
Table 7: CMO Market, India, Revenue ($bn), 2008-2010 27
Table 8: CMO Market, India, Revenue Forecasts ($bn), 2010-2018 27
Table 9: CMO Market, China, Revenue ($bn), 2008-2010 29
Table 10: CMO Market, China, Revenue Forecasts ($bn), 2010-2018 29
Table 11: CMO Market, Global, Market Drivers, All Employees: Index of Hourly Compensation Costs (United States = 100) 33
Table 12: CMO Market, Global, Market Drivers, Major Drug Patent Expirations, 2012-2018 36
Table 13: CMO Market, Global, Market Restraints, Reduction in Drug Approval Rates by FDA, 1996-2010 43
Table 14: CMO Market, Global, Market Restraints, Opportunities Lost by CMOs Due to Reduced Approval Rates by FDA 44
Table 15: CMO Market, Global, PIC/S Members from Eastern Europe 53
Table 16: CMO Market, Global, Upstream Processing in Biopharmaceuticals, Comparison of Upstream and Downstream Process 55
Table 17: CMO Market, Upstream Processing in Biopharmaceuticals, Revenue Forecast,($bn), 2009-2018 56
Table 18: CMO Market, Downstream Processing in Biopharmaceuticals, Revenue Forecast ($bn), 2009-2018 57
Table 19: CMO Market, Global, M&A, 2009-2011 72
Table 20: CMO Market, Global, Co-development Deals, 2009-2011 73
Table 21: CMO Market, Global, Licensing Deals, 2009-2011 76
1.2 List of Figures
Figure 1: CMO Market, Global, Cost Optimization Steps in the Pharmaceutical Industry 10
Figure 2: CMO Market, Global, Impact Analysis of Various Cost Optimization Methods 11
Figure 3: CMO Market, Global, Industry Structure 12
Figure 4: CMO Market, Global, Process for Selection of CMO and Management of Outsourcing Project 14
Figure 5: CMO Market, Global, Key Benefits of Outsourcing to CMOs 18
Figure 6: CMO Market, Global, Revenue Forecasts ($bn), 2008-2018 21
Figure 7: CMO Market, Global, Market Share by Services Provided %, 2010 22
Figure 8: CMO Market, Global, Revenue Split of Global CMO Market by Geography %, 2010 23
Figure 9: CMO Market, The US, Revenue Forecasts ($bn), 2008-2018 24
Figure 10: CMO Market, The Top Five European Countries Vs The Central and Eastern Europe Countries (%), 2010 25
Figure 11: CMO Market, The Central and Eastern Europe, Revenue Forecasts ($bn), 2008-2018 26
Figure 12: CMO Market, India, Revenue Forecasts ($bn), 2008-2018 27
Figure 13: CMO Market, China, Revenue Forecasts ($bn), 2008-2018 29
Figure 14: CMO Market, Global, Contract Manufacturing Organizations, Global Market Driver and Restraints 32
Figure 15: CMO Market, Global, Market Drivers, Difference in Hourly Wage Costs in Euro Area vs. Eastern Europe, 2009 33
Figure 16: CMO Market, Global, Market Drivers, Difference in Hourly Wage Costs in China vs. India, 2002-2008 34
Figure 17: CMO Market, Global, Market Drivers, Increasing Generics Opportunities Due to Patent Expiries for Major Drugs 39
Figure 18: CMO Market, Global, Market Drivers, IPR Protection Eastern European vs. Asian CMO Markets 40
Figure 19: CMO Market, Global, Market Restraints, Reduction in Drug Approval Rates by FDA, 1996-2010 43
Figure 20: CMO Market, Global, Market Restraints, Opportunities Lost by CMOs Due to Reduced Approval Rates by FDA 44
Figure 21: CMO Market, Global, Steps in API Manufacturing Governed by EU GMP Guidelines 50
Figure 22: CMO Market, Upstream Processing in Biopharmaceuticals, Revenue Forecast,($bn), 2009-2018 56
Figure 23: CMO Market, Downstream Processing in Biopharmaceuticals, Revenue Forecast ($bn), 2009-2018 57
Figure 24: CMO Market, Global, Company Profiles – Catalent Inc., 2010 58
Figure 25: CMO Market, Global, Company Profiles – Lonza Group AG, 2010 60
Figure 26: CMO Market, Global, Company Profiles – Royal DSM N.V., 2010 62
Figure 27: CMO Market, Global, Company Profiles – Piramal Healthcare, 2010 64
Figure 28: CMO Market, Global, Company Profiles – Jubilant Life Sciences, 2010 65
Figure 29: CMO Market, Global, Company Profiles – Evonik Industries AG, 2010 67
Figure 30: CMO Market, Global, Company Profiles – Patheon Inc., 2010 68
Figure 31: CMO Market, Global, Company Profiles – Fareva Holding, 2010 69
Figure 32: CMO Market, Global, Company Profiles – Cambrex, 2010 70
Figure 33: CMO Market, Global, Company Profiles – Boehringer Ingelheim, 2010 71
Companies mentioned
Catalent Pharma Solutions, Inc.
Lonza Group AG
Royal DSM N.V.
Piramal Healthcare Ltd.
Jubilant Life Sciences
Evonik Industries AG
Patheon Inc.
Fareva Holding
Cambrex
Boehringer Ingelheim
To order this report:
Manufacturing Industry: Contract Manufacturing Organizations to 2018 - Cost Advantages and Improving Quality Standards Build Confidence and Encourage Foreign Investment in Asian CMOs
Check our Industry Analysis and Insights
__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article